NIH-funded research R37 grant

Improving HIV care in developing countries

Official title: Optimizing HIV Care in Less Developed Countries

Funded at Massachusetts General Hospital · NIH-11092355 · Data updated 2026-11-12

This study is looking at how to improve HIV care in countries with fewer resources by using a computer model to find the best testing and treatment options for different groups of people, so that everyone can get better health support.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$8,781
NIH project number3R37AI058736-20S1
Project IDNIH-11092355 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV in less developed countries who are currently not receiving optimal care.

Less likely to help

Patients living with HIV in well-resourced countries with established treatment protocols may not benefit from this research.

What this research studies

This research aims to enhance the effectiveness of HIV care in less developed countries by utilizing a computer microsimulation model to analyze the natural history and management of HIV. It focuses on identifying the most effective testing and treatment strategies tailored to specific populations facing resource constraints. By expanding the Cost-Effectiveness of Preventing AIDS Complications International (CEPAC-I) Model, the research will evaluate novel treatments and develop innovative methods to optimize HIV care. The goal is to inform clinical policies that can lead to better health outcomes for individuals living with HIV.

Why it matters

Potential benefit: If successful, this research could lead to improved HIV treatment strategies that significantly reduce morbidity and mortality in affected populations.

How similar studies have gone: Previous research using similar modeling approaches has shown promise in optimizing healthcare strategies for infectious diseases, indicating potential for success in this area.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Freedberg, Kenneth Alan — Massachusetts General Hospital
  • Study coordinator: Freedberg, Kenneth Alan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.